ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
TC BioPharm Holdings PLC

TC BioPharm Holdings PLC (TCBP)

0.71
0.00
(0.00%)
Closed December 27 3:00PM
0.7881
0.0781
( 11.00% )
Pre Market: 8:29AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.7881
Bid
0.755
Ask
0.7881
Volume
400,677
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.71
Open
-
Last Trade Time
08:29:30
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
582,020
Dividend Yield
-
PE Ratio
-0.07
Earnings Per Share (EPS)
-10.15
Revenue
-
Net Profit
-5.91M

About TC BioPharm Holdings PLC

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Headquarters
Scotland, Gbr
Founded
-
TC BioPharm Holdings PLC is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker TCBP. The last closing price for TC BioPharm was US$0.71. Over the last year, TC BioPharm shares have traded in a share price range of US$ 0.00 to US$ 0.00.

TC BioPharm currently has 582,020 shares outstanding. The market capitalization of TC BioPharm is US$413,234.20 . TC BioPharm has a price to earnings ratio (PE ratio) of -0.07.

TCBP Latest News

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients PR Newswire EDINBURGH, Scotland, Dec. 20, 2024 EDINBURGH, Scotland, Dec. 20, 2024 /PRNewswire/ -- TC BioPharm...

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend PR Newswire EDINBURGH, Scotland, Dec. 18, 2024 EDINBURGH, Scotland, Dec. 18, 2024 /PRNewswire/ -- TC...

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy PR Newswire EDINBURGH, Scotland, Dec. 11, 2024 EDINBURGH...

TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial

TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial PR Newswire EDINBURGH, Scotland, Dec. 4, 2024 Positive safety data, allowing for exploration of higher TCB008 doses4 UK-based...

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant PR Newswire EDINBURGH, Scotland, Nov. 12, 2024 EDINBURGH, Scotland, Nov. 12, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...

TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements

TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements PR Newswire EDINBURGH, Scotland, Oct. 30, 2024 EDINBURGH, Scotland, Oct. 30, 2024 /PRNewswire/ -- TC BioPharm...

TCBP Responds to False Social Media Claim

TCBP Responds to False Social Media Claim PR Newswire EDINBURGH, Scotland, Oct. 25, 2024 TC BioPharm remains compliant with all Nasdaq listing requirements and will continue trading on the...

Biotech Shares Rip Following Collaboration Announcement For Monkeypox Research

A Scotland-based biotech company is finding a tremendous amount of success so far during Tuesday’s session after the company announced it entered into a research planning To read the full...

TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic

TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic PR Newswire EDINBURGH, Scotland, Oct. 22, 2024 EDINBURGH, Scotland, Oct. 22, 2024 /PRNewswire/...

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening PR Newswire EDINBURGH, Scotland, Oct. 3, 2024 TC BioPharm Limited is partnering with...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

TCBP - Frequently Asked Questions (FAQ)

What is the current TC BioPharm share price?
The current share price of TC BioPharm is US$ 0.7881
How many TC BioPharm shares are in issue?
TC BioPharm has 582,020 shares in issue
What is the market cap of TC BioPharm?
The market capitalisation of TC BioPharm is USD 413.23k
What is the 1 year trading range for TC BioPharm share price?
TC BioPharm has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of TC BioPharm?
The price to earnings ratio of TC BioPharm is -0.07
What is the reporting currency for TC BioPharm?
TC BioPharm reports financial results in GBP
What is the latest annual profit for TC BioPharm?
The latest annual profit of TC BioPharm is GBP -5.91M
What is the registered address of TC BioPharm?
The registered address for TC BioPharm is MAXIM 1, 2 PARKLANDS WAY, HOLYTOWN, SCOTLAND, ML1 4WR
What is the TC BioPharm website address?
The website address for TC BioPharm is www.tcbiopharm.com
Which industry sector does TC BioPharm operate in?
TC BioPharm operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
US$ 17.34
(0.00%)
276.91k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69.73
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.21
(0.00%)
4.84k
AACGATA Creativity Global
US$ 0.762551
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.34
(0.00%)
282.45k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69.73
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.21
(0.00%)
4.84k
AACGATA Creativity Global
US$ 0.762551
(0.00%)
0
NXUNXU Inc
US$ 0.2434
(0.00%)
125.6M
WATTEnergous Corporation
US$ 0.4112
(0.00%)
65.68M
VINCVincerx Inc
US$ 0.194
(0.00%)
28.14M
INTZIntrusion Inc
US$ 2.16
(0.00%)
27.09M
HOLOMicroCloud Hologram Inc
US$ 2.40
(0.00%)
26.76M

TCBP Discussion

View Posts
81vette 81vette 21 hours ago
https://ih.advfn.com/stock-market/NASDAQ/tc-biopharm-TCBP/stock-news/95121457/tcbp-announces-general-meeting-of-shareholders-to
👍️0
81vette 81vette 1 day ago
Divy,Jan 2nd(Thursday)how r ppl not jumping on this,what am I missing?
👍️0
81vette 81vette 4 days ago
.25 divy coming,seen massive runs on these before
👍️0
tw0122 tw0122 2 weeks ago
TCBP 1.23 + 160%
👍️0
tw0122 tw0122 2 weeks ago
TCBP 1.16 + 150% triple up
👍️0
tw0122 tw0122 2 weeks ago
Let double up $1.03 + 130%
👍 1 🚀 1
62bluejay 62bluejay 2 weeks ago
Does anyone have an opinion on the 3 voting options we received?
👍️0
David bond David bond 1 month ago
That was then now it's going to 142.00
👍️0
David bond David bond 1 month ago
Tcbp. Fintel has price target at $142.00 a share .no reverse split for a long time
👍️0
David bond David bond 1 month ago
Tcbp. Fintel has price target at $142.00 a share .no reverse split for a long time
👍️0
David bond David bond 1 month ago
Tcbp first case of mopx in California ...will need better vaccines
👍️0
David bond David bond 1 month ago
Tcbp first case of mopx in California ...will need better vaccines
👍️0
John_Langston John_Langston 1 month ago
TCBP was trading at about $0.20 on 11/21/22 when it did a 1 for 50 RS. Later TCBP was back down to about $0.20 on 12/15/23 when it did a 1 for 20 RS. Later TCBP was back down to about $0.50 on 8/5/24 when it did a 1 for 10 RS.
👍️ 1
frans frans 1 month ago
0.57 blocks down with 20 - 30.000 in 1 time
👍️0
Dyno89 Dyno89 1 month ago
Confirmed on ST board as well. 582k outstanding. 

Will have to keep an eye on the o/s figure for the next week. But this isn't an otc, it's Nasdaq. If it was otc I'd say it's the company playing games. But its not. 

So like I said, I can't see it being dilution, especially after the PR this week about $250,000 in "non dilutive" funding secured. 

When they added shares before, they PR'd it immediately as share offerings to raise cash for the clinical trials, etc. 
👍️0
frans frans 1 month ago
on my L2 showed many blocks 25.000 and more selling
👍️0
Dyno89 Dyno89 1 month ago
I understood what you were saying. 

It's rare but it happens especially on low floats.

https://www.investopedia.com/ask/answers/05/sharestradedoutstanding.asp

👍️0
SeniorApollo SeniorApollo 1 month ago
I don't think you are following my question.
I don't believe there is any possible way that every single shares was traded 50 times already today. Some thing didn't add up.
👍️0
Dyno89 Dyno89 1 month ago
Tcbp's official website confirms 582.02k o/s. Otcmarkets is outdated, maybe bc this is a Nasdaq stock. 
👍️0
Dyno89 Dyno89 1 month ago
Last I remember pre split, I think it was 9 mil. There was a split also a year ago. So the shares have decreased significantly twice in the past year. 

Most recent o/s I can find is about 582,000k

https://finance.yahoo.com/news/tcbp-awarded-non-dilutive-funding-143000233.html


Non dilutive $250,000 funding announced this week, so doesn't make sense they'd be diluting a few days later. Who knows. It's hard to find trustworthy info on it. The S****twits board is more active than here, but many manipulative bashers there. I remember post split months back someone saying the a/s was under 5 mil. 
👍️0
SeniorApollo SeniorApollo 1 month ago
What are the authorized shares? I can't seem to find that anywhere.

Otc shows 300k shares outstanding, and 24million volume today?

Something doesn't add up.
👍️0
Dyno89 Dyno89 1 month ago
Seen this happen a dozen times before bc it's such a low float and it wasn't ever dilution before. They just got a $250,000 grant too. Don't think they're diluting. It's just already held shares changing hands. 
👍️0
gail gail 1 month ago
yup, they dumped it fast, what a scam.
👍️0
frans frans 1 month ago
owt here
👍️0
SeniorApollo SeniorApollo 1 month ago
This has to be company dilution then. 10x volume compared to the OS?
👍️0
Dyno89 Dyno89 1 month ago
The market cap is insanely low for a clinical stage bio company. 

250k?!

They've already passed a stage 2b in UK. They get well into the FDA ones and a realistic market cap is in the hundreds of millions. 


👍️0
Dyno89 Dyno89 1 month ago
It's definitely under 1 million after the last r/s. 

Nothing about this stock makes any sense, been in it for almost two years. 

Was trading around $5-$7 over a year ago, then got beat down to well under $1. They did a r/s, became even more of a super low float and o/s. Traded around $4 again earlier this year, climbed up to around $6-$7 again recently. Then on nothing but continued good news and progress (plus a blatantly false Twitter post), it gets beat down to $2, then dumps to where we are under $1 again. 
👍️0
frans frans 1 month ago
running down now
👍️0
gail gail 1 month ago
i see its running now, maybe it had news.
👍️0
frans frans 1 month ago
this sell off - have you not some news for ???
👍️0
frans frans 1 month ago
company sell off into the market
👍️0
SeniorApollo SeniorApollo 1 month ago
Does anyone know that actually share structure here? Shares outstanding shows under 1 million and already 16 million volume today.
👍️0
frans frans 1 month ago
1 is selling into the market - I think the company
👍️0
frans frans 1 month ago
MM is short sometime 3 to 10 MM's together
👍️0
gail gail 1 month ago
not sure, but the mm (market maker….



called ARCX killed this run pushing it down. do you have L2 (level 2) to see detailed trades and how the mm’s are on the bid and ask?

i saw them show up and got worried they would push it down.
👍️ 1
frans frans 1 month ago
I see my

L2 big sell or company is selling or MM short
👍️ 1
south border south border 1 month ago
Why this low price ? 3 months ago the price was above $ 5 usd .... Any reason ? Sorry about my english
👍️0
gail gail 1 month ago
no hablo ‘en espanol, english please?
👍️0
south border south border 1 month ago
Hace 3 meses estaba en mas de $ 5 USD Algun motivo por que bajo tanto ? Gracias
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
I DON;T KNOW SOUNDS GOOD
👍️ 1
madras50 madras50 1 month ago
how so?
👍️0
gail gail 1 month ago
looks good t/t!
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
DOLLAR DOLLAR
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
TCBP JFK JR PLAY
👍️0
glenn1919 glenn1919 1 month ago
TCBP...........................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
TCBP BLOWING UP
👍️0
Dyno89 Dyno89 2 months ago
Right? I've been in this one for awhile now and it's beyond frustrating. Same pattern it's had for a year or two. 

There's been nothing but positive news on their progress since we were up around $6-$7 and now it's back under $1.

It's a super low float, so my hope is that there's a massive spike at some point on big clinical trial news or a buyout. 


👍️0
62bluejay 62bluejay 2 months ago
sorry good news
👍️0
62bluejay 62bluejay 2 months ago
How does a stock that only delivers continuously drop in pps?
👍️0

Your Recent History

Delayed Upgrade Clock